Innovative automatic fast and cost effective nanovesicles manufacturing equipm...
Innovative automatic fast and cost effective nanovesicles manufacturing equipment
The global nanovesicles market size was valued at $1.18 billion in 2016 and is expected to witness an attractive CAGR of 7.2% until 2021.
However, the current procedures for producing nanovesicles exhibit the following drawbacks:...
ver más
NANOVEX BIOTECHNOLOGIES
Cnae7211 investigación, desarrollo y prestación de servicios en el ámbito de la nanotecnología y la caracterización físico-quimica de nanoma...
TRL
4-5
| 130K€
Fecha límite participación
Sin fecha límite de participación.
Financiación
concedida
El organismo H2020 notifico la concesión del proyecto
el día 2019-09-30
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
CTQ2009-12128
NUEVAS PLATAFORMAS DE MICROFLUIDICA PARA LA MINIATURIZACION...
154K€
Cerrado
NextGenMicrofluidics
Next generation test bed for upscaling of microfluidic devic...
17M€
Cerrado
PRE2020-092267
TECNICAS DE MICROFLUIDICA PARA LA PRODUCCION Y MANIPULACION...
99K€
Cerrado
SBMP-microcarrier
SBMP - disrupting the manufacturing of biological drugs thro...
4M€
Cerrado
NANOFACTURING
The Development of Medium and Large Scale Sustainable Manuf...
9M€
Cerrado
PID2019-108278RB-C32
TECNICAS DE MICROFLUIDICA PARA LA PRODUCCION Y MANIPULACION...
127K€
Cerrado
Información proyecto NANOGO
Duración del proyecto: 5 meses
Fecha Inicio: 2019-04-30
Fecha Fin: 2019-09-30
Líder del proyecto
NANOVEX BIOTECHNOLOGIES
Cnae7211 investigación, desarrollo y prestación de servicios en el ámbito de la nanotecnología y la caracterización físico-quimica de nanoma...
TRL
4-5
| 130K€
Presupuesto del proyecto
71K€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
The global nanovesicles market size was valued at $1.18 billion in 2016 and is expected to witness an attractive CAGR of 7.2% until 2021.
However, the current procedures for producing nanovesicles exhibit the following drawbacks: i) Do not allow for small volume (require at least 10 ml production), ii) Have low reproducibility, iii) Require various sub-processes and many man hours, leading to variable results based on who has carried out the procedure; iv) Are expensive (it is often necessary to create a small number of nanovesicles given that the compounds that they encapsulate are extremely expensive); and v) Are non-scalable (not only have problems with scaling up to large quantities, but also with producing small quantities).
We at Nanovex Biotechnologies, increasingly disappointed with the current technologies for producing nanovesicles, have designed and prototyped NanoGo, a piece of microfluidics equipment that produces nanovesicles faster, better and at lower cost, for industrial applications.
NanoGo is capable of producing small volumes (0.5 ml) to large volumes (4 liters/day) of nanovesicles. In addition, NanoGo has many other advantages: i) High reproducibility: The automation of the process allows you to obtain nanovesicles with reproducible characteristics (size, encapsulation efficiency, distribution). The result is the same regardless of who uses it and how many times you repeat the procedure; ii) Rapid process: Requires just 20 minutes to produce 50 ml of nanovesicles; iii) Ease of use: Anyone can do so with no knowledge of formulation; iv) Low cost. Requires a low volume of samples per experiment; v) Very easy to scale up. It is quite simple to increase the scale (1 to 100 chips -for instance- working in parallel).